FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3

Journal of Clinical Investigation

Volumn 125, Issue 3, 2015, Pages 1111-1123

  Wang, Liqing ^a   Liu, Yujie ^a   Han, Rongxiang ^a   Beier, Ulf H ^b   Bhatti, Tricia R ^a   Akimova, Tatiana ^a   Greene, Mark I ^c   Hiebert, Scott W ^d,e   Hancock, Wayne W ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 3; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; HISTONE DEACETYLASE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; GENE EXPRESSION REGULATION; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY;

ANIMALS; AUTOIMMUNITY; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HEK293 CELLS; HISTONE DEACETYLASES; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY;

EID: 84924077253     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI77088     Document Type: Article

References (59)

1. Samstein RM, et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell. 2012;151(1):153-166.
2. Rudra D, et al. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat Immunol. 2012;13(10):1010-1019.
3. Shevach EM. Biological functions of regulatory T cells. Adv Immunol. 2011;112:137-176.
4. Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells. Immunity. 2013;38(3):414-423.
5. Riley JL, June CH, Blazar BR. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity. 2009;30(5):656-665.
6. Sakaguchi S, Vignali DA, Rudensky AY, Niec RE, Waldmann H. The plasticity and stability of regulatory T cells. Nat Rev Immunol. 2013;13(6):461-467.
7. Marek-Trzonkowska N,et al Administration of CD4+CD25highCD127-regulatory T cells preserves ?-cell function in type 1 diabetes in children Diabetes Care. 2012, 35, 9, 1817-1820.
8. Marek N, et al. The time is crucial for ex vivo expansion of T regulatory cells for therapy. Cell Transplant. 2011;20(11):1747-1758.
9. Trzonkowski P, et al. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+ CD25+CD127-T regulatory cells. Clin Immunol. 2009;133(1):22-26.
10. Tao R, et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med. 2007;13(11):1299-1307.
11. Liu Y, et al. Inhibition of p300 impairs Foxp3+ T regulatory cell function and promotes antitumor immunity. Nat Med. 2013;19(9):1173-1177.
12. Wang L, de Zoeten EF, Greene MI, Hancock WW. Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells. Nat Rev Drug Discov. 2009;8(12):969-981.
13. de Zoeten EF, Wang L, Sai H, Dillmann WH, Hancock WW. Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology. 2010;138(2):583-594.
14. Beier UH, Wang L, Han R, Akimova T, Liu Y, Hancock WW. Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms. Sci Signal. 2012;5(229):ra45.
15. Lahm A, et al. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci U S A. 2007;104(44):17335-17340.
16. Fischle W, Dequi edt F, Fillion M, Hendzel MJ, Voelter W, Verdin E. Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. J Biol Chem. 2001;276(38):35826-35835.
17. Gregoire S, e t al. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol. 2007;27(4):1280-1295.
18. Fischle W, et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell. 2002;9(1):45-57.
19. Guenther MG, Barak O, Lazar MA. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol. 2001;21(18):6091-6101.
20. Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY. Genome-wide analysis of Foxp3 target genes in dev eloping and mature regulatory T cells. Nature. 2007;445(7130):936-940.
21. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. Role of conserved non-coding DNA elemen ts in the Foxp3 gene in regulatory T-cell fate. Nature. 2010;463(7282):808-812.
22. Wang L, et al. Foxp3+ T-regulatory cells require DNA methyltransferase 1 expression to prevent development of lethal autoimmunity. Blood. 2013;121(18):3631-3639.
23. Guenther MG, Lane WS, Fischle W, Verdin E, Lazar MA, Shiekhattar R. A core SMRT corepressor complex c ontaining HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev. 2000;14(9):1048-1057.
24. Li J, et al. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 2000;19(16):4342-4350.
25. Wen YD, et al. The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc Natl Acad Sci U S A. 2000;97(13):7202-7207.
26. Watson PJ, Fairall L, Santos GM, Schwabe JW. Structure of HDAC3 bound to co-repressor and inositol tetraphosphate. Nature. 2012;481(7381):335-340.
27. Arr ar M, Turnham R, Pierce L, de Oliveira CA, McCammon JA. Structural insight into the separate roles of inositol tetraphosphate and deacetylase-Activating domain in activation of histone deacetylase 3. Protein Sci. 2013;22(1):83-92.
28. You SH,Lim HW,Sun Z,Broache M,Won KJ,Lazar MA Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo Nat Struct Mol Biol. 2013 ;20 2 182-187.
29. Lu L, et al. Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. J Immunol. 2010;184(8):4295-4306.
30. Takimoto T, et al. Smad2 and Smad3 are redundantly essential for the TGF-?-mediated regulation of regulatory T plasticity and Th1 development. J Immunol. 2010;185(2):842-855.
31. Che n L, Fischle W, Verdin E, Greene WC. Duration of nuclear NF-?B action regulated by reversible acetylation. Science. 2001;293(5535):1653-1657.
32. Kiernan R, et al. Post-Activation t urn-off of NF-?B-dependent transcription is regulated by acetylation of p65. J Biol Chem. 2003;278(4):2758-2766.
33. Knutson SK, Chyla BJ, Amann JM, Bhaskara S, Huppert SS, Hiebert SW. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. 2008;27(7):1017-1028.
34. Sun Z, Feng D, Everett LJ, Bugge A, Lazar MA. Circadian epigenomic remodeling and hepatic lipogenesis: lessons from HDAC3. Cold Spring Harb Symp Quant Biol. 2011;76:49-55.
35. Montgomery RL, et al. Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice. J Clin Invest. 2008;118(11):3588-3597.
36. Sun Z, et al. Diet-induced lethality due to deletion of the Hdac3 gene in heart and skeletal muscle. J Biol Chem. 2011;286(38):33301-33309.
37. Razidlo DF, et al. Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat. PLoS One. 2010;5(7):e11492.
38. McQuown SC, et al. HDAC3 is a critical negative regulator of long-term memory formation. J Neurosci. 2011;31(2):764-774.
39. Chen X, et al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc Natl Acad Sci U S A. 2012;109(42):E2865-2874.
40. Thapa P, et al. The transcriptional repressor NKAP is required for the development of iNKT cells. Nat Commun. 2013;4:1582.
41. Summers AR, et al. HDAC3 is essential for DNA replication in hematopoietic progenitor cells. J Clin Invest. 2013;123(7):3112-3123.
42. Wong RH, Chang I, Hudak CS, Hyun S, Kwan HY, Sul HS. A role of DNA-PK for the metabolic gene regulation in response to insulin. Cell. 2009;136(6):1056-1072.
43. Yuan Z, Peng L, Radhakrishnan R, Seto E. Histone deacetylase 9 (HDAC9) regulates the functions of the ATDC (TRIM29) protein. J Biol Chem. 2010;285(50):39329-39338.
44. Schuet z A, et al. Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity. J Biol Chem. 2008;283(17):11355-11363.
45. Bradner JE, et al. C hemical phylogenetics of histone deacetylases. Nat Chem Biol. 2010;6(3):238-243.
46. Mihaylova MM, et al. Class IIa histone deacetylases are hormone-Activated regulators of FOXO and mammalian glucose homeostasis. Cell. 2011;145(4):607-621.
47. Schapira M. Structural biology of human metal-dependent histone deacetylases. Handb Exp Pharmacol. 2011;206:225-240.
48. Wing JB, Sakaguchi S. Foxp3(+) T(reg) cells in humoral immunity. Int Immunol. 2014;26(2):61-69.
49. Reinhardt A, et al. CCR7-mediated migration in the thymus controls T-cell development. Eur J Immunol. 2014;44(5):1320-1329.
50. Cyster JG, Schwab SR. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol. 2012;30:69-94.
51. Sun Z, et al. Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor. Mol Cell. 2013;52(6):769-782.
52. Li B, et al. FOXP3 interaction s with histone acetyltransferase and class II histone deacetylases are required for repression. Proc Natl Acad Sci U S A. 2007;104(11):4571-4576.
53. Lee PP, et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity. 2001;15(5):763-774.
54. Rubtsov YP, et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 2008;28(4):546-558.
55. Bhaskara S, et al. Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Mol Cell. 2008;30(1):61-72.
56. Wang L, Han R, Hancock WW. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance. Eur J Immunol. 2007;37(10):2983-2990.
57. Aranda R, et al. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J Immunol. 1997;158(7):3464-3473.
58. No rthrop JK, Thomas RM, Wells AD, Shen H. Epigenetic remodeling of the IL-2 and IFN-? loci in memory CD8 T cells is influenced by CD4 T cells. J Immunol. 2006;177(2):1062-1069.
59. Battke F, Symons S, Nieselt K. Mayday-integrative analytics for expression data. BMC Bioinformatics. 2010;11:121.